We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Australian telehealth startup Eucalyptus has made $200 million in 18 months as demand for weight loss drugs soars. Here's how ...
AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...
You've probably heard about the relatively new weight loss medications and the results some people have seen with them and you may have wondered if they could help you.
What about the side-effects? Will I regain all my weight? Dr Sarah Jarvis has the answers to your burning questions.
AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire rights to a long-acting amylin ...
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.
Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results